On March 3, 2022 Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), an immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, reported that company management will participate in the 32nd Annual Oppenheimer Healthcare Conference, taking place virtually March 15-17, 2022 (Press release, Sensei Biotherapeutics, MAR 3, 2022, View Source [SID1234609473]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

John Celebi, MBA, president and chief executive officer of Sensei Biotherapeutics, and Erin Colgan, chief financial officer, will participate in a virtual presentation beginning at 10:40 am ET on Tuesday, March 15, 2022. A webcast of the presentation will be available on the Events & Presentations section of the Sensei website. A replay of the webcast will be on the website for approximately 90 days following the event.